Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Nonoperating Income (Expense) (QFRD110385USNO)

Observation:

Q4 2022: 13,290 (+ more)   Updated: Mar 20, 2023
Q4 2022:  13,290  
Q3 2022:  9,649  
Q2 2022:  4,430  
Q1 2022:  8,904  
Q4 2021:  11,918  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Nonoperating Income (Expense) [QFRD110385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFRD110385USNO, May 30, 2023.


Subscribe to the FRED newsletter


Follow us

Back to Top
Top